Aspivix’s Post

Attention #Medtech professionals! Are you interested in hemocompatibility, medical devices, and extracorporeal systems? Then, this exclusive editorial article is for you! It features experts Dr. Andy Herbert, CTO and Co-founder, and Dr. Elizabeth Blackburn, Principal Scientist at Invizius. Providing in-depth insights into the significance of assessing complement activation in dialysis. Don't miss out on this opportunity to enrich your knowledge and contribute to advancing healthcare solutions. Discover how Invizius is assessing complement activation and tackling its challenges. Click the link to download your copy and join the conversation on the relevance of hemocompatibility in extracorporeal systems. https://hubs.ly/Q02vv8PD0 Complement assessment could make a difference! #Hemocompatibility #ExtracorporealSystems #MedicalDevices #Dialysis #HealthcareInnovation #Biocompatibility #SvarLifeScience #ExpertPartner #AnswersinLifeScience #MedTech

𝐁𝐨𝐝𝐲 𝐂𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐳𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐓𝐫𝐞𝐧𝐝𝐬 [𝟐𝟎𝟐𝟗] 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> bit.ly/3z7iV68 The global #body_composition_analyzers market in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.2 billion by 2029, growing at a CAGR of 9.3% from 2024 to 2029. OMRON Group, Hologic, Inc., GE HealthCare, InBody, COSMED, OSTEOSYS CO., LTD, TANITA Europe B.V. - Leading Health Insights, Evolt, RJL Systems, Charder Medical, Samco Medical, BioTekna - Biomedical Technologies, SELVAS Healthcare, Inc., Swissray International #BodyCompTech #HealthMetrics #FitnessAnalytics #WellnessInnovation #BodyAnalysis #FitTech #PrecisionHealth #BodyScan #HealthMonitoring #WellnessTech #BodyCompInsights #FitnessTracking #HealthAssessment #SmartWellness #BodyMetrics

🌟 Thrilled to have represented Bioexcel - Your Medical Device Research Partner with Amandeep Kaur Sehmi at the ICMR headquarters in Delhi! 🌟 Had the privilege of attending the "Handholding Support to MedTech Innovators" workshop, organized under the MedTech Mitra initiative by #NITIAayog, #ICMR, and #CDSCO. The session was insightful and provided a deep dive into the essentials of regulation-compliant clinical investigations. Key highlights from the workshop: - Keynote Address: Dr. Vinod K Paul (NITI Aayog) - Regulatory Insights: Sh. Aseem Sahu & Sh. Pramod Meshram Rao (CDSCO) - Clinical Study Design: Dr. Aparna Mukherjee (ICMR) - Statistical Applications: Dr. Ravindra Mohan Pandey (ICMR) - Experience Sharing: Innovators on CDSCO-approved technologies Connecting with other innovators and experts in the field was truly rewarding. The discussions were not only informative but also paved the way for potential collaborations. Looking forward to applying the knowledge and insights gained to further our work at Bioexcel! 🚀 #MedTech #ClinicalResearch #Bioexcel #Innovation #Healthcare #ICMR #NITIAayog #CDSCO #medicaldevicecro

Unlocking Healthcare's Future: Remote Patient Monitoring (RPM) Market Set to Reach $207.5 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dyb2f4Wk The global #remotepatientmonitoring market was valued at $71.9 billion in 2023 and is projected to reach $207.5 billion by 2028, with a remarkable CAGR of 23.6% during the forecast period. Our latest research study provides a comprehensive analysis of industry trends, pricing, patents, conferences, key stakeholders, and market buying behavior. #rpm #healthcareinnovation AvaCare, Inc. Biofourmis Biotricity Inc. (NASDAQ:BTCY) Caretaker Medical | Advanced Hemodynamic Monitoring Chronolife ConnectedHealth Pte Ltd Current Health DarioHealth EarlySense Gauss Surgical, now a part of Stryker GlucoMe Hillrom iRhythm Technologies, Inc. Kardia Livongo Masimo Medtronic Nanowear Qardio, Inc. ResMed Sensogram Technologies, Inc. VitalConnect Vivify Health® X2 Biosystems

More tailwind is blowing inside BOYDSense's sails. 🌬️ The medical device company specialized in non-invasive glucose monitoring has raised a €7M capital increase. The round is led by the Swiss Diabetes Venture Fund and BioSerenity, with the participation of the European Innovation Council Fund. Historical investors Jolt Capital and Ambrosia Investments Group are also participating in this capital increase. This round follows the announcement of the latest convincing clinical studies in partnership with Toulouse University Hospital. To know more: https://lnkd.in/dSn8uGSu (on the picture, BOYDSense CEO Ben Delhey, demo-ing the Lassie glucose monitoring prototype) #fightdiabetes #diabetesmanagement #healthcare #privateequity #deeptech #breathanalyzer #diabete #diabetes #medtech #medicaldevice #chronicdisease #sensors #capteurs #essaiclinique #clinicaltrial #essaimedical #technologiemedicale #health #maladiechronique #digitalhealth #santenumerique #healthmonitoring #scaleupEurope #EICfund CHU de Toulouse French Healthcare #boydsense Alpha MOS Pierre Sbabo

📰 Exciting breakthrough from HTGmedical! Our intensive real-life testing at Fakultní nemocnice Olomouc has shown promising results. As Mgr. Michal Štýbnar from Národní telemedicínské centrum believes: "The HTG Urogram has the potential to significantly simplify and streamline the work of medical staff, not only in intensive care units". Discover how our innovation is set to save time for healthcare professionals and increase comfort for patients. Read more about our journey and the impact of HTG Urogram here (CZ only): https://lnkd.in/dmqh5J2S

Today, we're thrilled to #shine a #spotlight on one of our key business areas: our #medicaldevice! Did you know that at Sigrid, we are currently underway with the #SHINE #clinicaltrial? This trial is incredibly significant as it marks the largest ongoing Clinical Trial in #prediabetes. Our CEO, Sana Alajmovic , is currently on-site visiting one of our pivotal locations in Poland, with MTZ Clinical Research powered by Pratia. We extend our deepest gratitude to the amazing women collaborating in this groundbreaking process: 👩🔬 - Magdalena Sewastianowicz - Marta Zakrzewska - Dr. Anna Olak-Popko - Karolina Lewarska - Renata. Dudziak Together, we are leveraging the power of SiPore®️ technology, and we eagerly anticipate the progress and impact this trial will bring. Stay tuned for more updates on our journey of #innovation and dedication to promote healthier lives 💪 #MedicalDevice #Innovation #SHINEClinicalTrial #SiPoreTechnology #Healthcare #ClinicalResearch #Prediabetes #Type2Diabetes

🌟 Meet the Mirror Region North West Romania! 🇷🇴 FreshBlood HealthTech has been selected as a valuable project partner to drive collaboration and engagement among key players in the North West Romania region. 🚀 They will be teaming up with Medisprof to enhance collaboration between healthcare organizations and startups, co-developing solutions to the challenges defined. 🔍 The AITRIS Challenge: The main objective is to develop a digital solution to reduce the time for radiologist interpretation, increase the satisfaction of oncologists and radiologists for imaging results, leading to better follow-up of patient journeys and decreased radiology subcontracting costs. Their participation is crucial for driving the success and impact of the HealthChain project. 🌟 #HealthChain #DigitalHealth #innovation #Regionalcollaboration

Choosing iData Research for your MedTech research needs is a strategic move towards success. Here’s why: 🤝 Trustworthiness: Align your objectives and values with a company that's committed to delivering not just solutions, but the success you deserve. 💡 Experience: With iData Research, you bypass the generalists and work with specialists. Our focused expertise in MedTech research means we don't just deliver; we save you money and elevate your projects. 🔮 Future-Forward Solutions: Embrace the future with iData's advanced, procedure-based market sizing and brand-level analysis. Settle for nothing less than methodologies that lead the industry. 🙋♀️ Customer-Centric Service: Discover a healthcare market research partner that prioritizes your needs over profits. Our transparent methodology and full analyst access, combined with a try-before-you-buy approach, affirm our commitment to your success. #MedTech #ResearchExcellence #iDataResearch #HealthcareInnovation #medicaldevices #medicaldevice #dental #medtechinnovation #idataresearch

Bioimpedance Device Market Size, Share & Trends Analysis Report by Product Type (Single-Frequency Bioimpedance Devices, and Multiple-Frequency Bioimpedance Devices), by Modality (Wired Bioimpedance Devices, and Wireless Bioimpedance Devices), and by End-Users (Hospitals, Specialty Clinics, Rehabilitation Centers, and Others) Forecast Period (2024-2031) Get Sample of Report at:https://lnkd.in/dUQ4PmSi Bioimpedance device market is anticipated to grow at a CAGR of 9.6% during the forecast period (2024-2031). Bioimpedance devices are used instead of radiation to determine body composition, as they employ a safe electrical current. These are easier to operate, faster, more compact, and require no training some of them are even handheld. Numerous therapeutic domains, such as gastroenterology, chronic inflammation, postoperative surveillance, sports science, and many more, make extensive use of bioimpedance devices. Key Players:Akern Srl, Bioparhom, Bodystat Limited, Charder Medical, Fresenius Medical Care, ImpediMed, InBody, Maltron International Ltd, RJL Systems, SELVAS AI, among others. #BioimpedanceDevices #MedicalTechnology #BodyCompositionAnalysis #BioimpedanceMarket #NonInvasiveDiagnostics #MedicalDevices #HealthMonitoring #PatientCareTechnology #BiometricAnalysis #ElectroImpedance #MedicalEquipment #MedicalDiagnostics